Results 171 to 180 of about 6,796 (211)

Identifying global trends from case reports of fibrodysplasia ossificans progressiva: a scoping review. [PDF]

Ther Adv Musculoskelet Dis
Scott C, Al Mukaddam M, Davis M, De Cunto CL, Hsiao EC, Pignolo RJ, Schwegler O, Artyomenko A, Croskery K, Hanman K, Sanchot B, Warnants E, Kaplan FS.   +12 more
europepmc   +1 more source

Expression and distribution of activin-follistatin-inhibin axis in the urinary bladder. [PDF]

Front Mol Biosci
Mao W, Zhang T, Chen H, Barge S, Wang Z, Olumi A, Alper S, Yu W.   +7 more
europepmc   +1 more source

Efficacy and Safety of Momelotinib in Myelofibrosis: A Systematic Review and Meta-Analysis With a Focus on Anemia Outcomes. [PDF]

J Hematol
Al-Nusair J, Aldalal'ah M, Alqudah M, Al-Malkawi F, Al-Khateeb N, Khasawneh H, El-Shatel O, Khayyat O, Alseid SH, Abdallah M, Soudah O, Pacioles T, Jamil MO.   +12 more
europepmc   +1 more source

BMP-9 mediates fibroproliferation in fibrodysplasia ossificans progressiva through TGF-β signaling. [PDF]

EMBO Mol Med
Zhao C, Inada Y, Motoike S, Kamiya D, Hino K, Ikeya M.   +5 more
europepmc   +1 more source

Spinal cord injury-induced overflow incontinence reshapes the activin-follistatin-inhibin axis in mouse bladder and kidney. [PDF]

Front Mol Biosci
Shen Y, Yang S, Zhou H, Zhu Y, Wang Z, Jiang W.   +5 more
europepmc   +1 more source

Establishment of xenografts and methods to evaluate tumor burden for the three most frequent subclasses of pediatric-type diffuse high grade gliomas. [PDF]

J Neurooncol
Balaguer-Lluna L, Olaciregui NG, Aschero R, Resa-Pares C, Paco S, Cuadrado-Vilanova M, Burgueño V, Baulenas-Farres M, Monterrubio C, Manzanares A, Rodríguez E, Lavarino C, Mora J, Carcaboso AM.   +13 more
europepmc   +1 more source

Momelotinib for myelofibrosis. [PDF]

Aust Prescr
europepmc   +1 more source

Advancements in myelofibrosis management: a comprehensive analysis of Ojjaara (Momelotinib) therapy and clinical perspectives. [PDF]

Ann Med Surg (Lond)
Basaria AAA, Tariq R, Ahsan A, Ahsan AA, Wei CR, Bavurhe RF, Murhula JM, Bisimwa J, Akilimali A.   +8 more
europepmc   +1 more source

A systems approach identifies MERTK as a therapeutic vulnerability in ZFTA-RELA-driven ependymomas. [PDF]

Proc Natl Acad Sci U S A
Chan M, Zhu S, Russell ZR, Arora S, Arakaki AKS, Vaz JM, Kumasaka D, Szulzewsky F, Michealraj A, Holland EC, Gujral TS.   +10 more
europepmc   +1 more source

Targeting to BMP9 to restrain flare-up of fibrodysplasia ossificans progressiva. [PDF]

EMBO Mol Med
Li Q, Yuan Q.
europepmc   +1 more source